These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6450628)

  • 21. Continuous administration of barbital by pellet implantation.
    Flint BA; Ho IK
    J Pharmacol Methods; 1980 Sep; 4(2):127-39. PubMed ID: 7192783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol.
    Khanna JM; Kalant H; Chau A; Shah G
    Pharmacol Biochem Behav; 1998 Feb; 59(2):511-9. PubMed ID: 9477002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to, tolerance to, and physical dependence on ethanol and barbital in two inbred strains of rats.
    Suzuki T; Motegi H; Otani K; Koike Y; Misawa M
    Gen Pharmacol; 1992 Jan; 23(1):11-7. PubMed ID: 1592218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of p-chlorophenylalnine on the loss and maintenance of tolerance to ethanol.
    Frankel D; Khanna JM; Kalant H; Leblanc AE
    Psychopharmacology (Berl); 1978 Mar; 56(2):139-43. PubMed ID: 148066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of previous administration of adrenaline or isoprenaline on the activity of several hypnotics in mice].
    Dessaigne S; Scotto AM; Mercier J
    C R Seances Soc Biol Fil; 1976; 170(5):1074-80. PubMed ID: 192422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrandrine, a bisbenzylisoquinoline alkaloid from Chinese herb Radix, augmented the hypnotic effect of pentobarbital through serotonergic system.
    Zhao X; Cui XY; Chen BQ; Chu QP; Yao HY; Ku BS; Zhang YH
    Eur J Pharmacol; 2004 Dec; 506(2):101-5. PubMed ID: 15588729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiating effects of L-type Ca(2+) channel blockers on pentobarbital-induced hypnosis are influenced by serotonergic system.
    Zhao X; Cui XY; Chu QP; Chen BQ; Wang XM; Lin ZB; Li XJ; Ku BS; Zhang YH
    J Neural Transm (Vienna); 2006 Oct; 113(10):1395-402. PubMed ID: 16465463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social isolation and tolerance development to sodium barbital in mice.
    Faggin BM; Palermo-Neto J
    Braz J Med Biol Res; 1985; 18(2):223-6. PubMed ID: 3830284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotensin levels in specific brain regions and hypnotic sensitivity to ethanol and pentobarbital as a function of time after haloperidol administration in selectively bred rat lines.
    Erwin VG; Radcliffe R; Deitrich RA
    J Pharmacol Exp Ther; 2001 Nov; 299(2):698-704. PubMed ID: 11602683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of raphe lesions on the development of acute tolerance to ethanol and pentobarbital.
    Campanelli C; Lê AD; Khanna JM; Kalant H
    Psychopharmacology (Berl); 1988; 96(4):454-7. PubMed ID: 3149765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of cross-tolerance between barbiturates and phencyclidine.
    Flint BA; Ho IK
    Subst Alcohol Actions Misuse; 1980; 1(3):287-93. PubMed ID: 7347920
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of raphe lesions on the development of chronic tolerance to pentobarbital and cross-tolerance to ethanol.
    Khanna JM; Campanelli C; Lê AD; Kalant H
    Psychopharmacology (Berl); 1987; 91(4):473-8. PubMed ID: 3108927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute tolerance to barbiturate in the rat.
    Turnbull MJ; Watkins JW
    Eur J Pharmacol; 1976 Mar; 36(1):15-20. PubMed ID: 944131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of thalidomide and pentobarbital - new methods for identifying novel hypnotic drugs.
    Frederickson RC; Slater IH; Dusenberry WE; Hewes CR; Jones GT; Moore RA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):240-51. PubMed ID: 561842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Ro 15-4513 on the motor impairment and hypnotic effects of ethanol and pentobarbital.
    Le AD; Mana MJ; Pham T; Khanna JM; Kalant H
    Eur J Pharmacol; 1989 Jan; 159(1):25-31. PubMed ID: 2707299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on acute tolerance to ethanol in the abstinence period after long-term barbital treatment in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):152-60. PubMed ID: 573957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1974 Apr; 50(4):499-511. PubMed ID: 4155651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.